MAI Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.18M | Buy |
44,349
+68
| +0.2% | +$9.52K | 0.03% | 369 |
|
|
2025
Q4 | $5.44M | Buy |
44,281
+1,967
| +5% | +$239K | 0.03% | 377 |
|
|
2025
Q3 | $4.7M | Buy |
42,314
+13,649
| +48% | +$1.55M | 0.03% | 382 |
|
|
2025
Q2 | $3.18M | Buy |
28,665
+3,152
| +12% | +$335K | 0.02% | 410 |
|
|
2025
Q1 | $2.86M | Sell |
25,513
-789
| -3% | -$81.4K | 0.02% | 417 |
|
|
2024
Q4 | $2.43M | Buy |
26,302
+1,862
| +8% | +$168K | 0.02% | 444 |
|
|
2024
Q3 | $2.05M | Sell |
24,440
-4,161
| -15% | -$318K | 0.02% | 395 |
|
|
2024
Q2 | $1.96M | Sell |
28,601
-4,538
| -14% | -$303K | 0.02% | 415 |
|
|
2024
Q1 | $2.43M | Sell |
33,139
-2,060
| -6% | -$158K | 0.03% | 366 |
|
|
2023
Q4 | $2.85M | Sell |
35,199
-1,192
| -3% | -$92.8K | 0.04% | 266 |
|
|
2023
Q3 | $2.73M | Buy |
36,391
+2,208
| +6% | +$170K | 0.04% | 258 |
|
|
2023
Q2 | $2.63M | Sell |
34,183
-6,447
| -16% | -$514K | 0.04% | 252 |
|
|
2023
Q1 | $3.37M | Buy |
40,630
+6,961
| +21% | +$577K | 0.05% | 227 |
|
|
2022
Q4 | $2.89M | Buy |
33,669
+10,641
| +46% | +$843K | 0.05% | 232 |
|
|
2022
Q3 | $1.42M | Buy |
23,028
+8,592
| +60% | +$542K | 0.03% | 318 |
|
|
2022
Q2 | $892K | Buy |
14,436
+4,495
| +45% | +$278K | 0.02% | 412 |
|
|
2022
Q1 | $591K | Buy |
9,941
+2,402
| +32% | +$154K | 0.01% | 513 |
|
|
2021
Q4 | $547K | Buy |
7,539
+1,871
| +33% | +$129K | 0.01% | 545 |
|
|
2021
Q3 | $396K | Buy |
5,668
+1,131
| +25% | +$79.5K | 0.01% | 565 |
|
|
2021
Q2 | $312K | Sell |
4,537
-2,204
| -33% | -$147K | 0.01% | 591 |
|
|
2021
Q1 | $436K | Sell |
6,741
-1,037
| -13% | -$66.9K | 0.01% | 495 |
|
|
2020
Q4 | $453K | Sell |
7,778
-3,911
| -33% | -$236K | 0.01% | 466 |
|
|
2020
Q3 | $739K | Sell |
11,689
-11,995
| -51% | -$832K | 0.02% | 323 |
|
|
2020
Q2 | $1.82M | Buy |
23,684
+3,858
| +19% | +$296K | 0.06% | 177 |
|
|
2020
Q1 | $1.48M | Sell |
19,826
-2,864
| -13% | -$198K | 0.06% | 178 |
|
|
2019
Q4 | $1.47M | Sell |
22,690
-2,291
| -9% | -$149K | 0.05% | 217 |
|
|
2019
Q3 | $1.58M | Sell |
24,981
-1,672
| -6% | -$109K | 0.07% | 185 |
|
|
2019
Q2 | $1.8M | Buy |
26,653
+1,072
| +4% | +$70.5K | 0.08% | 177 |
|
|
2019
Q1 | $1.66M | Sell |
25,581
-595
| -2% | -$39.5K | 0.09% | 170 |
|
|
2018
Q4 | $1.64M | Sell |
26,176
-3,660
| -12% | -$256K | 0.1% | 166 |
|
|
2018
Q3 | $2.3M | Sell |
29,836
-1,410
| -5% | -$106K | 0.12% | 149 |
|
|
2018
Q2 | $2.21M | Sell |
31,246
-375
| -1% | -$26.5K | 0.12% | 152 |
|
|
2018
Q1 | $2.38M | Buy |
31,621
+573
| +2% | +$45.5K | 0.14% | 144 |
|
|
2017
Q4 | $2.22M | Buy |
31,048
+7,328
| +31% | +$556K | 0.13% | 145 |
|
|
2017
Q3 | $1.92M | Buy |
23,720
+504
| +2% | +$38.5K | 0.12% | 145 |
|
|
2017
Q2 | $1.64M | Buy |
23,216
+463
| +2% | +$30.8K | 0.11% | 152 |
|
|
2017
Q1 | $1.54M | Buy |
22,753
+2,755
| +14% | +$194K | 0.1% | 158 |
|
|
2016
Q4 | $1.43M | Sell |
19,998
-2,740
| -12% | -$204K | 0.1% | 153 |
|
|
2016
Q3 | $1.8M | Sell |
22,738
-875
| -4% | -$71.1K | 0.14% | 134 |
|
|
2016
Q2 | $1.97M | Sell |
23,613
-4,072
| -15% | -$361K | 0.15% | 127 |
|
|
2016
Q1 | $2.54M | Buy |
27,685
+1,014
| +4% | +$91.4K | 0.19% | 112 |
|
|
2015
Q4 | $2.7M | Buy |
26,671
+979
| +4% | +$102K | 0.21% | 112 |
|
|
2015
Q3 | $2.52M | Sell |
25,692
-7,357
| -22% | -$817K | 0.19% | 120 |
|
|
2015
Q2 | $3.87M | Sell |
33,049
-859
| -3% | -$93.9K | 0.25% | 106 |
|
|
2015
Q1 | $3.33M | Buy |
33,908
+26,666
| +368% | +$2.71M | 0.22% | 112 |
|
|
2014
Q4 | $683K | Sell |
7,242
-1,244
| -15% | -$129K | 0.05% | 257 |
|
|
2014
Q3 | $903K | Sell |
8,486
-895
| -10% | -$87.6K | 0.09% | 164 |
|
|
2014
Q2 | $778K | Buy |
9,381
+418
| +5% | +$32.5K | 0.07% | 173 |
|
|
2014
Q1 | $635K | Buy |
8,963
+2,591
| +41% | +$203K | 0.06% | 192 |
|
|
2013
Q4 | $479K | Buy |
+6,372
| New | +$444K | 0.05% | 230 |
|
Other funds holding GILD
VCM
VPM
MAI Capital Management's GILD Position: Q1 2026 in Review
MAI Capital Management increased its Gilead Sciences (GILD) stake by 0.15% in Q1 2026, buying an estimated $9.52K and bringing the position to 44,349 shares worth $6.18M. The position accounts for 0.03% of the portfolio, ranked #369.
MAI Capital Management first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- MAI Capital Management held 44,349 shares of Gilead Sciences worth $6.18M as of Q1 2026.
- MAI Capital Management bought 68 Gilead Sciences shares in Q1 2026, an estimated $9.52K.
- Gilead Sciences made up 0.03% of MAI Capital Management's portfolio in Q1 2026, its #369 holding.
- MAI Capital Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.